Skip to main content
. Author manuscript; available in PMC: 2008 May 2.
Published in final edited form as: J Acquir Immune Defic Syndr. 2007 Jan 1;44(1):30–37. doi: 10.1097/01.qai.0000248351.10383.b7

FIGURE 2.

FIGURE 2

Survival curves for time to treatment failure (A) and virologic failure (B). The vertical axis is the percentage of patients not yet having met the endpoint, and the horizontal axis is time in days. Patients whose adherence was classified as “poor” were significantly more likely to fail than those whose adherence was classified as “good.”